Thyrocare Q1 profits jump 34%, revenue up 24%
Thyrocare reported robust Q1 FY27 results with consolidated revenue of about ₹240 crore, up roughly 24% YoY, and consolidated net profit around ₹52.2 crore, up about 34% as the company benefits from higher test volumes and improved margins (EBITDA margin at 32.2%). The board approved both unaudited standalone and consolidated results and reappointed Ernst & Young LLP as internal auditors for FY2026-27, signaling strong governance amid continued double-digit growth in the diagnostics sector.